Al Benson, III, MD, FACp, Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center

Kim Lyerly, MD, Director, Duke Comprehensive Cancer Center

Amy Abernethy, MD, Director, Duke Cancer Care Research Program, Duke University School of Medicine

Robert Bast, MD, Vice President for Translational Research, MD Anderson Cancer Center

Michael Caligiuri, MD, Director, Ohio State University Comprehensive Cancer Center

William Dalton, MD, phD, CEO & Director, H. Lee Moffitt Cancer Center and Research Institute

William Nelson, MD, phD, Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Daniel Sargent, phD, Professor of Biostatistics, Professor of Oncology, Mayo Clinic

Ethan Basch, MD, MSc, Medical Oncologist & Health Services Researcher, Department of

Medicine and Department of Epidemiology, Memorial Sloan-Kettering Cancer Center

Food and Drug Administration Advisory Committee

Ed Benz, MD, President & CEO, Dana-Farber Cancer Institute

Michael Caligiuri, MD, Director, ohio State university Comprehensive Cancer Center

Bruce Chabner, MD, Clinical Director, Massachusetts General Hospital Cancer Center

John Marshall, MD, Chief, Division of Hematology/Oncology, Georgetown University Lombardi Comprehensive Cancer Center

Howard Scher, MD, Chief, Gernitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center

Richard Schilsky, MD, Professor of Medicine, Chief, Section of Hematology-Oncology, Deputy Director, Comprehensive Cancer Center, The University of Chicago Medical Center

Stephen Spielberg, MD, phD, Director of Personalized Medicine & Therapeutic Innovation, Children's Mercy Hospitals and Clinics

Robert Young, MD, President, RCYMedicine